Retatrutide 10mg
Lyophilised powder · Triple-agonist peptide · Vial
We don’t sell a compound until our own independent third-party testing is complete. This one is in verification — leave your email and we’ll tell you the moment its certificate of analysis is published.
Store at 2–8°C. Protect from light and moisture.
Independent Certificate of Analysis in progress — published once our own testing is complete.
About This Product
Retatrutide is an investigational peptide that works on three receptor pathways simultaneously — GIP, GLP-1, and glucagon. Most compounds in this category target only one or two.
Each vial contains 10mg lyophilised powder. Our own independent COA is pending.
Read the Retatrutide research guide→